Compréhension du mécanisme d’action des antidépresseurs anciens ou nouveaux : apport des modèles de souris génétiquement modifiées en pharmacologie in vivo
Author:
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effects of chronic paroxetine treatment on dialysate serotonin in 5‐HT1B receptor knockout miceJournal of Neurochemistry, 2003
- Improved efficacy of fluoxetine in increasing hippocampal 5-hydroxytryptamine outflow in 5-HT1B receptor knock-out miceEuropean Journal of Pharmacology, 2002
- Récepteurs 5-HT1B de la sérotonine et effets antidépresseurs des inhibiteurs de recapture sélectifs de la sérotonineComptes Rendus de l'Académie des Sciences - Series III - Sciences de la Vie, 2001
- Functional Consequences of 5-HT Transporter Gene Disruption on 5-HT1AReceptor-Mediated Regulation of Dorsal Raphe and Hippocampal Cell ActivityJournal of Neuroscience, 2001
- 5‐HT1B Autoreceptors limit the effects of selective serotonin re‐uptake inhibitors in mouse hippocampus and frontal cortexJournal of Neurochemistry, 2001
- Altered Brain Serotonin Homeostasis and Locomotor Insensitivity to 3,4-Methylenedioxymethamphetamine (“Ecstasy”) in Serotonin Transporter-Deficient MicMolecular Pharmacology, 1998
- Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory RegionScience, 1996
- Interaction between a selective 5‐HT1Areceptor antagonist and an SSRI in vivo: effects on 5‐HT cell firing and extracellular 5‐HTBritish Journal of Pharmacology, 1995
- Enhanced Aggressive Behavior in Mice Lacking 5-HT 1B ReceptorScience, 1994
- Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nucleiSynapse, 1993